Project cooperationUpdated on 7 December 2025
We seek cooperation in R&D, preclinical validation and regulatory studies to co-develop innovative solutions for the treatment of infected chronic wounds.
CEO at M2D1 Biossegurança
Santo André, Brazil
About
M2D1 is a Brazilian deep-tech company focused on developing advanced technologies for the management of infected chronic wounds. Our health project, BST22, is currently in preclinical validation and was designed to reduce microbial load, address biofilms and improve clinical outcomes through a safe, non-invasive approach.
We integrate biomedical engineering, applied microbiology, embedded intelligence and regulatory requirements to create an innovative medical device that supports healthcare professionals in treating complex wounds, including diabetic, pressure and vascular ulcers.
We seek international partners for cooperation in R&D, preclinical validation, regulatory studies and the design of future clinical trials. We are also interested in Horizon Europe consortia involving emerging medical technologies, infection management, healthy ageing and integrated care solutions.
M2D1 brings technical expertise, scientific rigor and active participation in innovation ecosystems, offering qualified contributions to high-impact collaborative health projects.
Organisation
Similar opportunities
Project cooperation
Cell Therapy for Vascular Wounds - Gut Microbiota Modulation as a Therapeutic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
Stefano De Monte
Cluster Manager - Life Science Cluster Friuli Venezia Giulia at Life Science Cluster Friuli Venezia Giulia
Trieste, Italy
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Jan Vícha
Senior researcher at Tomas Bata University in Zlín
Zlin, Czech Republic
Project cooperation
Innovative phage-based antimicrobial therapies to tackle AMR in Horizon Europe projects
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Silvia Angeletti
Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy